Differential expression and DNA methylation of angiotensin type 1A receptors in vascular tissues during genetic hypertension development

Molecular and Cellular Biochemistry

Volumn 402, Issue 1-2, 2015, Pages 1-8

  Pei, Fang ^a,b,c   Wang, Xinquan ^b   Yue, Rongchuan ^b   Chen, Caiyu ^b   Huang, Ji ^c   Huang, Jie ^c   Li, Xiaohui ^a   Zeng, Chunyu ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c Chongqing Municipal Corps Hospital of Chinese People's Armed Police Force   (China)

Author keywords

Artery; AT1 receptor; DNA methylation; Hypertension; SHRs

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; BISULFITE; MESSENGER RNA; ANGIOTENSIN 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE MEASUREMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; ELEVATED BLOOD PRESSURE; HEREDITARY HYPERTENSION; MALE; MESENTERIC ARTERY; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; RAT; VASCULAR TISSUE; WESTERN BLOTTING; ANIMAL; GENE EXPRESSION; GENETIC EPIGENESIS; GENETICS; HYPERTENSION; METABOLISM; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANIMALS; AORTA; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION; HYPERTENSION; MALE; MESENTERIC ARTERIES; PROMOTER REGIONS, GENETIC; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 84925539645     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2295-9     Document Type: Article

References (36)

1. Unger T, Paulis L, Sica DA (2011) Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches. Eur Heart J 32(22):2739–2747
2. Bader M (2010) Tissue renin-angiotensin-aldosterone systems: targets for pharmacological therapy. Annu Rev Pharmacol Toxicol 50:439–465
3. Savoia C, Burger D, Nishigaki N et al (2011) Angiotensin II and the vascular phenotype in hypertension. Expert Rev Mol Med 13:e11
4. Navar LG, Prieto MC, Satou R et al (2011) Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol 11(2):180–186
5. Dasgupta C, Zhang L (2011) Angiotensin II receptors and drug discovery in cardiovascular disease. Drug Discov Today 16(1–2):22–34
6. Aplin M, Bonde MM, Hansen JL (2009) Molecular determinants of angiotensin II type 1 receptor functional selectivity. J Mol Cell Cardiol 46(1):15–24
7. Higuchi S, Ohtsu H, Suzuki H et al (2007) Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 112(8):417–428
8. Nguyen Dinh Cat A, Touyz RM (2011) Cell signaling of angiotensin II on vascular tone: novel mechanisms. Curr Hypertens Rep 13(2):122–128
9. Kitami Y, Okura T, Marumoto K et al (1992) Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the rat. Biochem Biophys Res Commun 188(1):446–452
10. Llorens-Cortes C, Greenberg B, Huang H et al (1994) Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 24(5):538–548
11. Gasc JM, Shanmugam S, Sibony M et al (1994) Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study. Hypertension 24(5):531–537
12. Du Y, Guo DF, Inagami T et al (1996) Regulation of ANG II-receptor subtype and its gene expression in adrenal gland. Am J Physiol 271(2 Pt 2):H440–H446
13. Nguyen Dinh Cat A, Montezano AC, Burger D et al (2013) Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. Antioxid Redox Signal 19(10):1110–1120
14. Imaizumi S, Miura S, Yahiro E et al (2013) Class- and molecule-specific differential effects of angiotensin II type 1 receptor blockers. Curr Pharm Des 19(17):3002–3008
15. Frey FJ (2005) Methylation of CpG islands: potential relevance for hypertension and kidney diseases. Nephrol Dial Transplant 20(5):868–869
16. Bogdarina I, Welham S, King PJ et al (2007) Epigenetic modification of the renin- angiotensin system in the fetal programming of hypertension. Circ Res 100(4):520–526
17. Friso S, Pizzolo F, Choi SW et al (2008) Epigenetic control of 11 beta- hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension. Atherosclerosis 199(2):323–327
18. Smolarek I, Wyszko E, Barciszewska AM et al (2010) Global DNA methylation changes in blood of patients with essential hypertension. Med Sci Monit 16(3):CR149–CR155
19. +–2Cl– cotransporter 1 is epigenetically regulated during postnatal development of hypertension. Am J Hypertens 24(12):1286–1293
20. Bellavia A, Urch B, Speck M et al (2013) DNA hypomethylation, ambient particulate matter, and increased blood pressure: findings from controlled human exposure experiments. J Am Heart Assoc 2(3):e000212
21. Wang X, Falkner B, Zhu H et al (2013) A genome-wide methylation study on essential hypertension in young African American males. PLoS One 8(1):e53938
22. Wang F, Demura M, Cheng Y et al (2014) Dynamic CCAAT/enhancer binding protein-associated changes of DNA methylation in the angiotensinogen gene. Hypertension 63(2):281–288
23. Meissner A, Mikkelsen TS, Gu H et al (2008) Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454(7205):766–770
24. Jones PA (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 13(7):484–492
25. Deaton AM, Bird A (2011) CpG islands and the regulation of transcription. Genes Dev 25(10):1010–1022
26. Maunakea AK, Nagarajan RP, Bilenky M et al (2010) Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466(7303):253–257
27. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408
28. Viswanathan M, Tsutsumi K, Correa FM et al (1991) Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun 179(3):1361–1367
29. Millis RM (2011) Epigenetics and hypertension. Curr Hypertens Rep 13(1):21–28
30. Pojoga LH, Williams JS, Yao TM et al (2011) Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension. Am J Physiol Heart Circ Physiol 301(5):H1862–H1871
31. Chu CH, Lo JF, Hu WS et al (2012) Histone acetylation is essential for ANG-II-induced IGF-IIR gene expression in H9c2 cardiomyoblast cells and pathologically hypertensive rat heart. J Cell Physiol 227(1):259–268
32. Lee HA, Lee DY, Lee HJ et al (2012) Enrichment of (pro)renin receptor promoter with activating histone codes in the kidneys of spontaneously hypertensive rats. J Renin Angiotensin Aldosterone Syst 13(1):11–18
33. Lee HA, Cho HM, Lee DY et al (2012) Tissue-specific upregulation of angiotensin-converting enzyme 1 in spontaneously hypertensive rats through histone code modifications. Hypertension 59(3):621–626
34. Batkai S, Thum T (2012) MicroRNAs in hypertension: mechanisms and therapeutic targets. Curr Hypertens Rep 14(1):79–87
35. Bird A (2007) Perceptions of epigenetics. Nature 447(7143):396–398
36. Marx V (2012) Epigenetics: reading the second genomic code. Nature 491(7422):143–147